These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7610991)

  • 1. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
    Tanaka K; Arita H
    Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of bioavailable inhibitors of secretory phospholipase A2.
    Blanchard SG; Andrews RC; Brown PJ; Gan LS; Lee FW; Sinhababu AK; Wheeler TN
    Pharm Biotechnol; 1998; 11():445-63. PubMed ID: 9760691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of secretory phospholipase A2 group IIA.
    Reid RC
    Curr Med Chem; 2005; 12(25):3011-26. PubMed ID: 16378502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
    Niessen HW; Krijnen PA; Visser CA; Meijer CJ; Erik Hack C
    Cardiovasc Res; 2003 Oct; 60(1):68-77. PubMed ID: 14522408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional site of endogenous phospholipase A2 inhibitor from python serum.
    Thwin MM; Satish RL; Chan ST; Gopalakrishnakone P
    Eur J Biochem; 2002 Jan; 269(2):719-27. PubMed ID: 11856333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of type II secreted phospholipase A2 in inflammatory processes].
    Jacques C; Berenbaum F
    C R Seances Soc Biol Fil; 1996; 190(4):437-43. PubMed ID: 8952894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A(2) with anti-inflammatory activity.
    Murari SK; Sriharsha SN; Shashikanth S; Vishwanath BS
    Bioorg Med Chem Lett; 2004 May; 14(10):2423-5. PubMed ID: 15109625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018.
    Sales TA; Marcussi S; Ramalho TC
    Curr Med Chem; 2020; 27(3):477-497. PubMed ID: 30706775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of secretory phospholipase A2 in acute chest syndrome.
    Kuypers FA; Styles LA
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):87-94. PubMed ID: 15040432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages.
    Hidi R; Vial D; Havet N; Berger A; Vargaftig BB; Touqui L
    Biochem Pharmacol; 1997 Nov; 54(9):1055-8. PubMed ID: 9374427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting phospholipase A2 for the treatment of inflammatory skin diseases.
    Burke JR
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1549-52. PubMed ID: 11763156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phospholipase A2 inhibitors].
    Tanaka K; Arita H; Inoue K
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1987-99. PubMed ID: 8210439
    [No Abstract]   [Full Text] [Related]  

  • 13. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
    Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
    J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
    Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
    Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiphlogistic effectiveness of combinations of inhibitors of phospholipase A2, cyclooxygenase and lipoxygenases of the arachidonic acid cascade].
    Bekemeier H; Hirschelmann R
    Pharmazie; 1986 Apr; 41(4):260-2. PubMed ID: 3088612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marine natural products targeting phospholipases A2.
    Folmer F; Jaspars M; Schumacher M; Dicato M; Diederich M
    Biochem Pharmacol; 2010 Dec; 80(12):1793-800. PubMed ID: 20833149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a direct inhibitory effect of glucocorticoids on the activity of phospholipase A2 as a further possible mechanism of some actions of steroidal anti-inflammatory drugs.
    Mentz P; Giessler C; Förster W
    Pharmacol Res Commun; 1980 Sep; 12(8):817-27. PubMed ID: 7443764
    [No Abstract]   [Full Text] [Related]  

  • 18. [A family of receptors for secretory phospholipases A2].
    Lambeau G; Ancian P; Nicolas JP; Cupillard L; Zvaritch E; Lazdunski M
    C R Seances Soc Biol Fil; 1996; 190(4):425-35. PubMed ID: 8952893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors.
    Fox N; Song M; Schrementi J; Sharp JD; White DL; Snyder DW; Hartley LW; Carlson DG; Bach NJ; Dillard RD; Draheim SE; Bobbitt JL; Fisher L; Mihelich ED
    Eur J Pharmacol; 1996 Jul; 308(2):195-203. PubMed ID: 8840132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.
    Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D
    J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.